Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi

Gelijkaardige items

• Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia
  door: Danaë Martinez Flores, et al.
  Gepubliceerd in: (2024-07-01)
• Characteristics of autologous peripheral blood stem cells collection over a one-year period
  door: Gorana Ahmetović-Karić, et al.
  Gepubliceerd in: (2020-08-01)
• Evaluation of blood cell count using an automatic hematology analyzer to optimize collection of peripheral blood progenitor cells by leukapheresis
  door: Paula Renata Machado Passos Pederzoli, et al.
  Gepubliceerd in: (2024-12-01)
• Early Orbital Relapse in Mantle Cell Lymphoma: Rarity, Risk, and Transplant Strategy
  door: Georgiana ENE, et al.
  Gepubliceerd in: (2026-03-01)
• Is the Optimal Timing First Complete Remission for Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma?
  door: Bahar UNCU ULU, et al.
  Gepubliceerd in: (2021-08-01)